Company Filing History:
Years Active: 1996
Title: Innovations of Henry C McGill, Jr.
Introduction
Henry C McGill, Jr. is a notable inventor based in San Antonio, TX (US). He has made significant contributions to the field of biomedical research, particularly in the area of atherosclerosis treatment. With a total of 2 patents, his work has the potential to impact the medical community significantly.
Latest Patents
Henry's latest patents focus on CETP inhibitor polypeptide antibodies. These antibodies are designed to inhibit cholesteryl ester transfer protein (CETP). His inventions include an anti-atherosclerosis composition that comprises an effective amount of the polypeptide and a pharmaceutically acceptable carrier. Additionally, he has developed an anti-atherosclerosis kit that contains the composition, a syringe, and a needle in separate sterile containers. His work also details methods for preventing and treating atherosclerosis in mammals, showcasing the therapeutic potential of his polypeptide inventions.
Career Highlights
Henry C McGill, Jr. is affiliated with the Southwest Foundation for Biomedical Research. His career has been marked by a commitment to advancing medical science through innovative research and development.
Collaborations
Some of his notable coworkers include Rampratap Kushwaha and Patrick Kanda. Their collaborative efforts contribute to the ongoing research and development in the field of biomedical science.
Conclusion
Henry C McGill, Jr. stands out as an influential inventor in the biomedical field, with his patents paving the way for advancements in atherosclerosis treatment. His contributions are vital to the ongoing efforts to improve health outcomes for individuals at risk of this condition.